Delivery Order SPE2DB22D3501-SPE2DB25FUU83
- Not listed
- This federal contract award, valued at $1,136.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a medical product, and has an ultimate completion date of December 10, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG tablets, a pharmaceutical product, with a ceiling value of $2,500.51 and a completion date of September 25, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, with a ceiling value of $1,035.84 and a performance period ending on May 28, 2025. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.03, is for the delivery of the prescription medication Jolessa 0.15 mg-0.03 mg tablet. The contract is not a set-aside and is a firm fixed-price delivery order, with a performance period through May 2, 2025. AmerisourceBergen Drug Corp, based in Conshohocken, Pennsylvania, is...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Jolessa 0.15 mg-0.03 mg tablets, a pharmaceutical product, with a ceiling value of $1,178.45 and a performance period ending on June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Jolessa 0.15 mg-0.03 mg tablet. The contract has a ceiling value of $1,162.66 and a period of performance through June 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,727.16, is for the delivery of the prescription medication JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has an ultimate completion date of September 12, 2022 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,104.25 firm-fixed-price contract is for the supply of Jolessa 0.15 mg-0.03 mg tablets. The contract has an ultimate completion date of April 17, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S to the Defense Logistics Agency (DLA). The $1,222.96 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 4, 2024, with an ultimate completion date of October 7, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is associated with...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FUU83Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,110.83, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of March 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/5/25 |